Medicare Enrolled

Dr. Raman Gopalakrishnan, MD

Psychiatry · West Chester, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1570 MCDANIEL DR, West Chester, PA 19380
4844442151
In practice since 2005 (20 years)
NPI: 1982688271 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gopalakrishnan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gopalakrishnan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gopalakrishnan

Dr. Raman Gopalakrishnan is a psychiatry specialist in West Chester, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gopalakrishnan performed 943 Medicare services across 304 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gopalakrishnan received a total of $8,426 from 32 pharmaceutical and/or device companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gopalakrishnan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 12% volume in PA $8,426 industry payments

Medicare Practice Summary

Medicare Utilization ↗
943
Medicare services
Top 12% in PA for psychiatry
304
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
563 $82 $175
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
251 $135 $212
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
60 $148 $250
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
43 $26 $49
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $57 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,426
Total received (2018-2024)
Avg $1,204/year across 7 years
Top 7% in PA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
500
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,163 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$262 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,500
2023
$2,161
2022
$1,657
2021
$1,316
2020
$512
2019
$234
2018
$44

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$449
Neurocrine Biosciences, Inc.
$319
Alkermes, Inc.
$302
Axsome Therapeutics, Inc.
$292
Otsuka America Pharmaceutical, Inc.
$238
ABBVIE INC.
$228
Corium, LLC
$193
Lundbeck LLC
$119
Teva Pharmaceuticals USA, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$65
Almatica Pharma LLC
$43
Bausch Health US, LLC
$42
Noven Therapeutics, LLC
$42
IDORSIA PHARMACEUTICALS US INC
$34
Janssen Pharmaceuticals, Inc
$29
Neos Therapeutics, LP
$19
Lilly USA, LLC
$15
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,061
Neurocrine Biosciences, Inc.
$836
ABBVIE INC.
$746
Alkermes, Inc.
$680
ITI, Inc.
$531
Corium, LLC
$482
Lundbeck LLC
$457
Axsome Therapeutics, Inc.
$453
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$449
Takeda Pharmaceuticals U.S.A., Inc.
$408
Teva Pharmaceuticals USA, Inc.
$347
AbbVie Inc.
$316
Sunovion Pharmaceuticals Inc.
$212
Allergan, Inc.
$169
Allergan Inc.
$167
Vanda Pharmaceuticals Inc.
$151
Janssen Pharmaceuticals, Inc
$130
IDORSIA PHARMACEUTICALS US INC
$126
Ironshore Pharmaceuticals Inc.
$117
Bausch Health US, LLC
$106
Merck Sharp & Dohme LLC
$94
Avanir Pharmaceuticals, Inc.
$65
Lilly USA, LLC
$63
Noven Therapeutics, LLC
$61
Almatica Pharma LLC
$43
Eisai Inc.
$35
Biogen, Inc.
$24
Merck Sharp & Dohme Corporation
$22
JAZZ PHARMACEUTICALS INC.
$22
OWP Pharmaceuticals, Inc.
$20
Neos Therapeutics, LP
$19
Neuronetics, Inc.
$15
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADUHELM · AMYVID · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · Dayvigo · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · NUEDEXTA · Nuedexta · QUVIVIQ · REXULTI · SECUADO · SUBVENITE · SUNOSI · Sunosi · TRINTELLIX · UZEDY · VIVITROL · VRAYLAR · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in PA.

Looking for a psychiatry specialist in West Chester?
Compare psychiatrists in the West Chester area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
1,064
Per 100K population
196.7
County median income
$123,041
Nearest hospital
CHESTER COUNTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gopalakrishnan is a clinical cardiology specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement in the top 7% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gopalakrishnan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gopalakrishnan performed 563 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gopalakrishnan receive payments from pharmaceutical companies?
Yes. Dr. Gopalakrishnan received a total of $8,426 from 32 companies across 500 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gopalakrishnan's costs compare to other psychiatrists in West Chester?
Dr. Gopalakrishnan's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gopalakrishnan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →